跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COMBANTRIN-1 mebendazole 100mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
COMBANTRIN-1 mebendazole 100mg tablet blister pack
Approved
STANDARD
COMBANTRIN-1 mebendazole 100mg tablet blister pack
Johnson & Johnson Pacific Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
644c000ca067c32b
Company
Johnson & Johnson Pacific Pty Ltd
Type
Standard
Approval Details
Approval Id
644c000ca067c32b
Product Name
COMBANTRIN-1 mebendazole 100mg tablet blister pack
Artg Id
57119
Artg Name
COMBANTRIN-1 mebendazole 100mg tablet blister pack
Sponsor
Johnson & Johnson Pacific Pty Ltd
Company Detail Path
/organization/johnson-and-johnson-pacific-pty-ltd
Artg Date
1996-09-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
644c000ca067c32b
Type
Standard
Back to TGA Approvals
